Chemo-radiotherapy in head and neck cancer.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Annals of Oncology

• Publication date

  2006-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/ANNONC/MDL233PMID 17018748
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trial.

  2006cited by this paper
• Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis.

  2006cited by this paper
• French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).

  2006cited by this paper
• Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.

  2006cited by this paper
• Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000-01.

  2006cited by this paper
• Concomitant chemotherapy and radiation therapy certainly improves local control.

  2005influential reference
• Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.

  2005cited by this paper
• Introducing the BECT (biologically enhanced cytotoxic treatment) concept in cancer treatment.

  2005cited by this paper
• Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501)

  2005cited by this paper
• Intensity-modulated radiation therapy in the treatment of head and neck cancer

  2005cited by this paper
• Hyperfractionated accelerated chemoradiation with concurrent fluorouracil-mitomycin is more effective than dose-escalated hyperfractionated accelerated radiation therapy alone in locally advanced head and neck cancer: final results of the radiotherapy cooperative clinical trials group of the German

  2005cited by this paper
• Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial.

  2005cited by this paper
• Cetuximab in recurrent/metastatic (R&M) squamous cell carcinoma of the head and neck (SCCHN) refractory to first-line platinum-based therapies

  2005cited by this paper
• Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy

  2004cited by this paper
• Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.

  2004cited by this paper
• Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer.

  2004cited by this paper
• Update of MACH-NC (Meta-Analysis of Chemotherapy in Head & Neck Cancer) database focused on concomitant chemoradiotherapy.

  2004cited by this paper
• Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck.

  2004cited by this paper
• Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil–cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck

  2004cited by this paper
• Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems.

  2003cited by this paper
• Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer.

  2003cited by this paper
• Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.

  2001cited by this paper
• Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data

  2000cited by this paper
• Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma.

  1999cited by this paper
• Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.

  1998cited by this paper
• Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy.

  1992cited by this paper

• Oncolytic senecavirus A in tumor immunotherapy: Mechanisms, progress, and future directions.

  2024cites this paper
• Clinical Conundrum: Unveiling a Unique Presentation of Hypopharyngeal Carcinoma

  2024cites this paper
• RETRACTED ARTICLE: Effect of radiotherapy on head and neck cancer tissues in patients receiving radiotherapy: a bioinformatics analysis-based study

  2024cites this paper
• CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL.

  2020cites this paper
• The evaluation of the intensity of radiation reaction using Dische scale in prediction of swallowing dysfunction and quality of life deterioration in patients with head and neck cancer treated with combined therapy including surgery, chemotherapy and radi

  2017cites this paper
• Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus-Related Oropharyngeal Carcinoma.

  2016influential citation
• Concomitant boost chemoradiotherapy in locally advanced head and neck cancer: treatment tolerance and acute side effects.

  2015cites this paper
• A Review of Chemotherapy for Locally Advanced Head and Neck Cancers

  2015cites this paper
• Human papillomavirus-related oropharyngeal squamous cell carcinoma: a new context for dysphagia rehabilitation

  2014cites this paper
• Two-year results of a prospective preventive swallowing rehabilitation trial in patients treated with chemoradiation for advanced head and neck cancer

  2014cites this paper
• Evaluation de combinaisons thérapeutiques ciblées en cancérologie des voies aérodigestives supérieures. Mise au point d’un modèle tumoral in vivo

  2014cites this paper
• Pre- and posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: expert listeners' and patient's perception.

  2012cites this paper
• UvA-DARE ( Digital Academic Repository ) Preventive rehabilitation in patients treated with chemoradiation for advanced head and neck cancer

  2011cites this paper
• Preventive rehabilitation in patients treated with chemoradiation for advanced head and neck cancer

  2011cites this paper
• Current concepts of management in radiotherapy for head and neck squamous-cell cancer.

  2009cites this paper
• Targeting important pathways in head and neck cancer: from the bench to the clinic

  2008cites this paper
• Long-term results of concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: a phase II trial of the radiation therapy oncology group (RTOG 99-14).

  2008cites this paper
• Human papillomavirus in HNSCC: recognition of a distinct disease type.

  2008cites this paper
• Advances in nasopharyngeal carcinoma

  2008cites this paper
• EGFR inhibition as a therapy for head and neck squamous cell carcinoma.

  2008cites this paper
• EGFR inhibition as a therapy for head and neck squamous cell carcinoma

  2008cites this paper
• Biological agents in head and neck cancer

  2007cites this paper
• Molecular biology for the radiation oncologist: the 5Rs of radiobiology meet the hallmarks of cancer.

  2007cites this paper
• Targeted therapies in head and neck cancer

  2007cites this paper
• Head and neck radiation and mucositis

  2007cites this paper
• Treatment of advanced neck metastases.

  2006cites this paper
• Treatment of advanced neck metastases Il trattamento delle metastasi laterocervicali in stadio avanzato

  2006cites this paper
• Prediction models for tube feeding dependence in head and neck radiotherapy

  year unknowncites this paper